Search
for
Sort by
Research 31–60 of 1000+
- PROTAC Degraders of Androgen Receptor‐Integrated Dissolving Microneedles for Androgenetic Alopecia and Recrudescence Treatment via Single Topical Administration
- The deduced sequence of the novel protransglutaminase E (TGase3) of human and mouse
- Exogen, Shedding Phase of the Hair Growth Cycle: Characterization of a Mouse Model
- Hair Follicular Expression and Function of Group X Secreted Phospholipase A2 in Mouse Skin
- Transient bullous dermolysis of the newborn
- Biochemistry of skin in health and disease
- Histological evaluation of hair follicle due to papain's depilatory effect
- Matriptase Expression and Zymogen Activation in Human Pilosebaceous Unit
- In vitro biodegradation of hair from different animal species by Microsporum canis
- Wounds and the Microbiota: The Healing Interplay Between Host and Microbial Communities
- Epidermal/Dermal Separation Techniques and Analysis of Cell Populations in Human Skin Sheets
- Liquid Chromatography-Mass Spectrometry Applied to The Identification And Quantification Of Animal Hair Fibers In Textile Products
- Cleave but not leave: Astrotactin proteins in development and disease
- Keratinocyte Stem Cells: Role in Aging
- Advantages of Incomplete Digestion in Human Hair Shaft Proteomics, a Focus on Cuticular Keratins
- 851 The role of astrotactin2 in regulating mammalian skin polarity
- Molecular elements of the regulatory control of keratin filament modulator AHF/trichohyalin in the hair follicle
- Explant culture: An advantageous method for isolation of mesenchymal stem cells from human tissues
- Recent Advances in Peptide Drug Discovery: Novel Strategies and Targeted Protein Degradation
- Transient Bullous Dermolysis of the Newborn
- Advancing PROTAC therapeutics through chemistry-guided design of smart delivery systems
- PROTACs in 2025: from the laboratory concept to clinical breakthrough
- Advancing Design Strategy of PROTACs for Cancer Therapy
- PROTACs: A novel strategy for cancer drug discovery and development
- PROTACs in cancer therapy: targeted degradation of GPX4, PARP and epigenetic regulators
- Proteasome Inhibitors: An Expanding Army Attacking a Unique Target
- A Top-Down Design Approach for Generating a Peptide PROTAC Drug Targeting Androgen Receptor for Androgenetic Alopecia Therapy
- Clinical Translation of Targeted Protein Degraders
- De novo designed bifunctional proteins for targeted protein degradation
- Characterization of the exocuticle a‐layer proteins of wool